Autologous bone marrow transplantation for pediatric Hodgkin's disease

A case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry

C. D. Williams, A. H. Goldstone, R. Pearce, S. Green, James Olen Armitage, A. Carella, G. Meloni

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Purpose: We analyzed the outcome of autologous bone marrow transplantation (ABMT) in pediatric and adult patients with Hodgkin's disease (HD) by means of a case-controlled study. Patients and Methods: Eighty-one pediatric HD patients who had undergone ABMT and who had been reported to the European Bone Marrow Transplant Group (EBMTG) Lymphoma Registry were compared with a case-matched group of 81 adult patients who had undergone the same procedure. The case-matching was performed following selection of the main prognostic factors for progression-free survival (PFS) by multivariate analysis. Results: The PFS rate was not significantly different between the groups (39% for the pediatric group v 48% for the adult group). The overall relapse/progression rates for the groups were 52% and 40%, respectively. This was not a statistically significant difference and the sites of relapse were similar. There was no significant difference in the incidence or causes of procedure-related morbidity or mortality of the two groups. Conclusion: This study suggests that patients with pediatric HD have the same outcome at ABMT as their adult counterparts; however, long-term complications will need to be carefully monitored.

Original languageEnglish (US)
Pages (from-to)2243-2249
Number of pages7
JournalJournal of Clinical Oncology
Volume11
Issue number11
DOIs
StatePublished - Jan 1 1993

Fingerprint

Autologous Transplantation
Bone Marrow Transplantation
Hodgkin Disease
Registries
Lymphoma
Bone Marrow
Pediatrics
Transplants
Disease-Free Survival
Recurrence
Survival Analysis
Research Design
Multivariate Analysis
Survival Rate
Morbidity
Mortality
Incidence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Autologous bone marrow transplantation for pediatric Hodgkin's disease : A case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry. / Williams, C. D.; Goldstone, A. H.; Pearce, R.; Green, S.; Armitage, James Olen; Carella, A.; Meloni, G.

In: Journal of Clinical Oncology, Vol. 11, No. 11, 01.01.1993, p. 2243-2249.

Research output: Contribution to journalArticle

@article{0979f9fa40714e1d9424ef0801e413b7,
title = "Autologous bone marrow transplantation for pediatric Hodgkin's disease: A case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry",
abstract = "Purpose: We analyzed the outcome of autologous bone marrow transplantation (ABMT) in pediatric and adult patients with Hodgkin's disease (HD) by means of a case-controlled study. Patients and Methods: Eighty-one pediatric HD patients who had undergone ABMT and who had been reported to the European Bone Marrow Transplant Group (EBMTG) Lymphoma Registry were compared with a case-matched group of 81 adult patients who had undergone the same procedure. The case-matching was performed following selection of the main prognostic factors for progression-free survival (PFS) by multivariate analysis. Results: The PFS rate was not significantly different between the groups (39{\%} for the pediatric group v 48{\%} for the adult group). The overall relapse/progression rates for the groups were 52{\%} and 40{\%}, respectively. This was not a statistically significant difference and the sites of relapse were similar. There was no significant difference in the incidence or causes of procedure-related morbidity or mortality of the two groups. Conclusion: This study suggests that patients with pediatric HD have the same outcome at ABMT as their adult counterparts; however, long-term complications will need to be carefully monitored.",
author = "Williams, {C. D.} and Goldstone, {A. H.} and R. Pearce and S. Green and Armitage, {James Olen} and A. Carella and G. Meloni",
year = "1993",
month = "1",
day = "1",
doi = "10.1200/JCO.1993.11.11.2243",
language = "English (US)",
volume = "11",
pages = "2243--2249",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "11",

}

TY - JOUR

T1 - Autologous bone marrow transplantation for pediatric Hodgkin's disease

T2 - A case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry

AU - Williams, C. D.

AU - Goldstone, A. H.

AU - Pearce, R.

AU - Green, S.

AU - Armitage, James Olen

AU - Carella, A.

AU - Meloni, G.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Purpose: We analyzed the outcome of autologous bone marrow transplantation (ABMT) in pediatric and adult patients with Hodgkin's disease (HD) by means of a case-controlled study. Patients and Methods: Eighty-one pediatric HD patients who had undergone ABMT and who had been reported to the European Bone Marrow Transplant Group (EBMTG) Lymphoma Registry were compared with a case-matched group of 81 adult patients who had undergone the same procedure. The case-matching was performed following selection of the main prognostic factors for progression-free survival (PFS) by multivariate analysis. Results: The PFS rate was not significantly different between the groups (39% for the pediatric group v 48% for the adult group). The overall relapse/progression rates for the groups were 52% and 40%, respectively. This was not a statistically significant difference and the sites of relapse were similar. There was no significant difference in the incidence or causes of procedure-related morbidity or mortality of the two groups. Conclusion: This study suggests that patients with pediatric HD have the same outcome at ABMT as their adult counterparts; however, long-term complications will need to be carefully monitored.

AB - Purpose: We analyzed the outcome of autologous bone marrow transplantation (ABMT) in pediatric and adult patients with Hodgkin's disease (HD) by means of a case-controlled study. Patients and Methods: Eighty-one pediatric HD patients who had undergone ABMT and who had been reported to the European Bone Marrow Transplant Group (EBMTG) Lymphoma Registry were compared with a case-matched group of 81 adult patients who had undergone the same procedure. The case-matching was performed following selection of the main prognostic factors for progression-free survival (PFS) by multivariate analysis. Results: The PFS rate was not significantly different between the groups (39% for the pediatric group v 48% for the adult group). The overall relapse/progression rates for the groups were 52% and 40%, respectively. This was not a statistically significant difference and the sites of relapse were similar. There was no significant difference in the incidence or causes of procedure-related morbidity or mortality of the two groups. Conclusion: This study suggests that patients with pediatric HD have the same outcome at ABMT as their adult counterparts; however, long-term complications will need to be carefully monitored.

UR - http://www.scopus.com/inward/record.url?scp=0027445737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027445737&partnerID=8YFLogxK

U2 - 10.1200/JCO.1993.11.11.2243

DO - 10.1200/JCO.1993.11.11.2243

M3 - Article

VL - 11

SP - 2243

EP - 2249

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 11

ER -